Genome‐wide association study‐based deep learning for survival prediction

• Published in: Statistics in medicine Vol. 39; no. 30; pp. 4605 - 4620
• Main Authors: Sun, Tao, Wei, Yue, Chen, Wei, Ding, Ying
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 30.12.2020
• Subjects: AMD progression; Deep learning; Genomes; GWAS; predictor importance; survival prediction; predictor importance; deep learning; AMD progression; GWAS; survival prediction
• ISSN: 0277-6715; 1097-0258; 1097-0258
• DOI: 10.1002/sim.8743

Informative and accurate survival prediction with individualized dynamic risk profiles over time is critical for personalized disease prevention and clinical management. The massive genetic data, such as SNPs from genome‐wide association studies (GWAS), together with well‐characterized time‐to‐event phenotypes provide unprecedented opportunities for developing effective survival prediction models. Recent advances in deep learning have made extraordinary achievements in establishing powerful prediction models in the biomedical field. However, the applications of deep learning approaches in survival prediction are limited, especially with utilizing the wealthy GWAS data. Motivated by developing powerful prediction models for the progression of an eye disease, age‐related macular degeneration (AMD), we develop and implement a multilayer deep neural network (DNN) survival model to effectively extract features and make accurate and interpretable predictions. Various simulation studies are performed to compare the prediction performance of the DNN survival model with several other machine learning‐based survival models. Finally, using the GWAS data from two large‐scale randomized clinical trials in AMD with over 7800 observations, we show that the DNN survival model not only outperforms several existing survival prediction models in terms of prediction accuracy (eg, c‐index =0.76), but also successfully detects clinically meaningful risk subgroups by effectively learning the complex structures among genetic variants. Moreover, we obtain a subject‐specific importance measure for each predictor from the DNN survival model, which provides valuable insights into the personalized early prevention and clinical management for this disease.